| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/25/2009 | CN100471492C Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 03/25/2009 | CN100471491C Toluene sulfonamide-containing anti-tumor composition and method of use thereof |
| 03/25/2009 | CN100471490C Sesquiterpene ketone injection, preparing method and use thereof |
| 03/25/2009 | CN100471486C Immunomodulatory compositions, methods of making, and methods of use thereof |
| 03/24/2009 | US7507851 Halocombstatins and methods of synthesis thereof |
| 03/24/2009 | US7507841 Cannabinoid receptor modulator |
| 03/24/2009 | US7507839 e,g, 1,5-bis(5-acetyl-4,7-dimethoxybenzofuran-6-yloxy)pentane;potassium channel modulator; antiinflammatory agent, autoimmune diseases; immunosuppressant; multiple sclerosis, rejection of foreign organ transplants |
| 03/24/2009 | US7507836 Benzamide modulators of metabotropic glutamate receptors |
| 03/24/2009 | US7507835 e.g. [2-(1-(Benzenesulfonyl)-1H-indol-3-yloxy)ethyl]dimethylamine; serotonin, melatonin receptor ligand; antidepressant, anxiolytic agent; cognition activator; psychosis, schizophrenia, migraine headache, drug addiction, convulsions, osteoporosis, ischemic stroke, Alzheimer's, Parkinson's diseases |
| 03/24/2009 | US7507834 Cyclin dependent kinases (CDK2) inhibitors; 4-[5-(3-bromo-phenyl)-2H-pyrazol-3-ylamino]-benzenesulfonamide; cancer and hyperproliferative diseases, such as psoriasis |
| 03/24/2009 | US7507833 e.g. 5-(3-(2-(4-(1-hydroxyhexyl)phenyl)-3-oxopyrazolidin-1-yl)propyl)thiophene-2-carboxylic acid; glaucoma or ocular hypertension |
| 03/24/2009 | US7507832 Triazole PPAR modulators |
| 03/24/2009 | US7507831 Therapy for breast cancer; plant extracts; 4-[(2-benzothiazolyl)thio]-5,7,3',4'-tetra-O-benzyl-epicatechin, 4-[(2-benzothiazolyl)thio]-5,7,3',4'-tetra-O-benzyl-catechin, 4-[(2-benzothiazolyl)thio]-3-O-acetyl-5,7,3',4'-tetra-O-benzyl-epicatechin |
| 03/24/2009 | US7507828 Such as quinoline-8-carboxylic acid [5-(2-mercapto-acetylamino)-pentyl]-amide; increasing sensitivity of cancer cells to radiotherapy cytotoxic effects; neurological diseases |
| 03/24/2009 | US7507824 Spiro(2H-1benzopyran-2,4′-piperidine) derivates as glycine transport inhibitors |
| 03/24/2009 | US7507823 Water is introduced to a stream of supercritical fluid which is then allowed to mix with a stream including a mixture including aripiprazole and a solvent; mixing results in the substantially simultaneous dispersion and extraction of the aripiprazole from the mixture by the supercritical fluid |
| 03/24/2009 | US7507817 Glaucome therapy; vision defects |
| 03/24/2009 | US7507816 Compounds for treatment of inflammation, antidepressants, nervous system disorders, cardiovascular disorders or analgesics from mannich reaction |
| 03/24/2009 | US7507815 Succinoylamino lactams as inhibitors of a-β protein production |
| 03/24/2009 | US7507807 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders |
| 03/24/2009 | US7507803 Optimized multi-epitope constructs and uses thereof |
| 03/24/2009 | US7507798 Antibody specific for mutant presenilin 1 |
| 03/24/2009 | US7507769 Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| 03/24/2009 | US7507768 Administering a tablet designed to control moisture containing metformin and glipizide and having a protective coating or finishing layer; glipizide does not hydrolyze and the metformin is compressible; does not have an enteric coating |
| 03/24/2009 | US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity |
| 03/24/2009 | US7507766 Treatment of cancers |
| 03/24/2009 | US7507765 Mevalonic acid derivatives; antitumor/anticancer agents |
| 03/24/2009 | US7507764 Amphiphilic [5:1]- and [3:3]- hexakisadducts of fullerenes |
| 03/24/2009 | US7507763 Enzyme inhibitor for treating HIV infections in mammals; viricides; patient is suffering from a multi-drug resistant HIV infection; Aids therapy |
| 03/24/2009 | US7507762 Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2009 | US7507761 Benzopyran derivatives, method of production and use thereof |
| 03/24/2009 | US7507760 Strokes, hypotensive agents, antidepressants,central nervous system disorders, psychological disorders, schizophrenia, alcoholism, drug abuse |
| 03/24/2009 | US7507759 Methods of using(+)-2-[1-(3-ethoxy-4methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3,-dione |
| 03/24/2009 | US7507758 4-alkyl-/4-alkenyl-/4-alkynyl methyl/-1-aryl-cyclohexylamine compounds |
| 03/24/2009 | US7507757 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 03/24/2009 | US7507756 (2-Chlorophenyl)-[2-(1-isopropyl-piperidin-4-ylmethoxy)-3-methyl-3H-imidazol-4-yl]-]-methanone; histamine receptor antagonist; neurologic disorders; reacting imidazole compound with base and perhaloalkane, to form 2-haloimidazole, and with electrophile to form C-5 position substituted imidazole compound |
| 03/24/2009 | US7507755 Inhibitors of cathepsin s |
| 03/24/2009 | US7507754 e.g. N-{4-[4-(5-Methoxy-pyridin-2-yl)-phenoxymethyl]-5-methyl-furan-2-carbonyl}-2-methyl-benzenesulfonamide; prostaglandin E4 receptor antagonist; analgesic, antiinflammatory agent; migraines and headache |
| 03/24/2009 | US7507753 Biaryl compound and use thereof |
| 03/24/2009 | US7507752 A C9-deoxomeridamycin, used as a neuroregenerative agent |
| 03/24/2009 | US7507751 Biphenyl derivatives |
| 03/24/2009 | US7507750 e.g. L-Ascorbic acid-2-phosphoric acid-6-(2'-hexyldecanoate) sodium salt; collagen production accelerators; skin whitening; medical, pharmaceutical preparations, feeds, foods and agrochemicals; storage stability, |
| 03/24/2009 | US7507749 Antitumor agents |
| 03/24/2009 | US7507748 e.g. 2-(7-isoquinolinylamino)-N-(3-methyl-4-(1-methylethyl)phenyl)-3-pyridinecarboxamide; Vascular Endothelial Growth Factor antagonist; angiogenesis inhibitor; anticarcinogenic, antiinflammatory inhibitor; retinopathies, rheumatoid arthritis, asthma, atherosclerosis, endometriosis, neoplastic diseases |
| 03/24/2009 | US7507747 Muscarinic acetylcholine receptor antagonists |
| 03/24/2009 | US7507746 Enantiomer of tenatoprazole and the use thereof in therapy |
| 03/24/2009 | US7507745 Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins |
| 03/24/2009 | US7507744 Spiroazabicyclic heterocyclic compounds |
| 03/24/2009 | US7507743 Substituted 8′-pyridinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a] pyrimidin-6-one and 8′-pyrimidinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a] pyrimidin-6-one derivatives |
| 03/24/2009 | US7507742 Spirocyclic derivatives |
| 03/24/2009 | US7507741 Heterocyclic compounds |
| 03/24/2009 | US7507740 Fused heterocyclic compound |
| 03/24/2009 | US7507739 Against tumors expressing multiple drug resistance by promoting microtubule polymerization; deesterification of a phenyldiester with 3-amino-1,2,4-triazole, halogenation with a phosphorusoxyhalide, amination with a perfluoroalkylamine in the presence of a strong base and aprotic solvent |
| 03/24/2009 | US7507738 Intermediates to anticancer agents, NK1 antagonists, or elastase inhibitors; 2-(alkoxy, aryl, alkyl, alkylamino or alkylthio)-6-oxo-5-(protected amino)-1,6-dihydropyrimidine by reacting an N-protected glycine ester with dimethylformamidedimethylacetal, reacting with acid and then amidine compound |
| 03/24/2009 | US7507737 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4receptor |
| 03/24/2009 | US7507736 Indol-2-yl-piperazin-1-yl-methanone derivatives |
| 03/24/2009 | US7507735 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 4-[(3-fluoro-5-{[(6-methyl(3-pyridyl))amino]carbonylamino}-phenyl)methyl]piperazinecarboxylate |
| 03/24/2009 | US7507734 Pyridazinone derivatives |
| 03/24/2009 | US7507733 11b-HSD1 inhibitors for the treatment of diabetes |
| 03/24/2009 | US7507732 6,7-Dihydro-5H-cyclopenta[b]pyridine and 5,6,7,8-tetrahydroquinoline compounds; 5-HT2c receptor agonists; to treat diseases like obesity, depression, atypical depression, anxiety, epilepsy, lower urinary tract dysfunction; less toxic; selectivity |
| 03/24/2009 | US7507731 Compounds for use in weight loss and appetite suppression in humans |
| 03/24/2009 | US7507730 Substituted pyrazolo[1,5-a]pyrimidines as potassium channel activators |
| 03/24/2009 | US7507729 Substituted imidazo-[1,5-a][1,2,4]triazolo[1,5-d][1,4] benzodiazepine derivatives |
| 03/24/2009 | US7507728 for the treatment of cognitive disorders, anxiety, schizophrenia, and Alzheimer's disease; 10-chloro-9H-imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine; ligands; GABA A alpha 5 receptor inhibitors; halogenation |
| 03/24/2009 | US7507726 Antibiotic; bactericides |
| 03/24/2009 | US7507725 Compounds with sulphonamide group and pharmaceutical compositions containing these compounds |
| 03/24/2009 | US7507724 capable of enhancing efficacy of vaccines; capable of enhancing the action of an agent in preventing tissue rejection |
| 03/24/2009 | US7507723 Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 03/24/2009 | US7507722 Delivering polynucleotides to skeletal muscle cells in a limb by inserting an injector into an artery in the limb; impeding blood flow to the surface of the skin (e.g., via a tourniquet or blood pressure cuff); and injecting a solution containing the polynucleotides through the injector |
| 03/24/2009 | US7507721 3'-amidic macrolide derivatives lacking cladinose; treatment of respiratory and gastrointestinal diseases |
| 03/24/2009 | US7507720 5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 03/24/2009 | US7507715 Administering parathyroid hormone and bone resorption inhibitor; bone disorders |
| 03/24/2009 | US7507707 phosphodiesterase inhibitor; follicle stimulating hormone; clomiphene; anovulation disorder; collecting oocytes for in vitro fertilization; aromatase inhibitor |
| 03/24/2009 | US7507705 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 03/24/2009 | US7507572 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains |
| 03/24/2009 | US7507564 Tiacumicin production |
| 03/24/2009 | US7507563 culturing propionibacterium under anaerobic conditions, in medium containing a carbon source such as lactose, to form 1,4-dihydroxynaphthalene-2-carboxylic acid, having a good flavor, useful for foods, beverages and drugs |
| 03/24/2009 | US7507545 Ion channel modulating activity method |
| 03/24/2009 | US7507541 36P6D5: secreted tumor antigen |
| 03/24/2009 | US7507540 determining the presence of catalytic antibodies capable of degrading antihemophilic factors in mammals; analyzing the cleavage sites in the antihemophilic factors; biocatalysts; drugs |
| 03/24/2009 | US7507529 genetic amplification of a target nucleic acid in biological samples containing primate T-lymphotropic viruses (PTLVs), include human and simian T-lymphotropic viruses (HTLV and STLV), and detecting the strain of PTLV contained in the sample by determining nucleotide fragments that have been amplified |
| 03/24/2009 | US7507421 From aqueous extract of Garcinia cambogia/indica fruits; tasteless; for use in foods |
| 03/24/2009 | US7507420 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 03/24/2009 | US7507412 for drug screening; kits for collagen and/or platelet-collagen interaction; for treatment of thrombotic and cardiovascular events and disorders |
| 03/24/2009 | US7507407 Immunoliposomes that optimize internationalization into target cells |
| 03/24/2009 | US7507398 Using condensation aerosol (MMAD of less than 5 microns) formed by vaporizing a thin layer of the drug on a solid support and condensing the vapor to treat anxiety, vertigo, alcohol or nicotine withdrawal, sedation, hot flashes, peptic ulcers or for hormone replacement therapy, or pregnancy prevention |
| 03/24/2009 | US7507397 Delivery of muscle relaxants through an inhalation route |
| 03/24/2009 | US7507196 Antisense antiviral compounds and methods for treating a filovirus infection |
| 03/24/2009 | CA2606275C Method for preparing and using water-based steroid pheromone compositions |
| 03/24/2009 | CA2604112A1 Adipose resolve apparatus for low-power laser |
| 03/24/2009 | CA2520979C Formulations of ecteinascidins |
| 03/24/2009 | CA2508897C Process for manufacture of a composition for supplementing animals with solutions of essential metal amino acid complexes |
| 03/24/2009 | CA2508824C Alpha crystalline form of strontium ranelate, its preparation process, and the pharmaceutical compositions that contain it |
| 03/24/2009 | CA2487586C Feed supplemented with ketoprofen and its use in the simultaneous treatment of conditions causing fever, inflammation and/or pain in a herd of animals |
| 03/24/2009 | CA2431100C Dihydroindole and tetrahydroquinoline derivatives |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/24/2009 | CA2421738C Purine ribosides as antiarrhythmics |
| 03/24/2009 | CA2390558C Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same |
| 03/24/2009 | CA2382404C Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 03/24/2009 | CA2377904C Medicament with a protective effect against oxidative-toxic substances, particularly against cardiotoxic substances |